ANGPTL4 and hepatocellular carcinoma: This observation is in agreement with our results showing that recombinant ANGPTL4 impairs Akt activation in muscle cells, and that ANGPTL4 ablation in hepatoma cells protects muscle cells from CM-3a core induced IR.